Dani JA, Donnelly-Roberts D, Bertrand D (2015)
Nicotinic acetylcholine receptors as therapeutic targets: Emerging frontiers in basic research and clinical science--Editorial Comments
Biochemical Pharmacology 97: 351

Minami SS, Shen V, Le D, Krabbe G, Asgarov R, Perez-Celajes L, Lee CH, Li J, Donnelly-Roberts D, Gan L (2015)
Reducing inflammation and rescuing FTD-related behavioral deficits in progranulin-deficient mice with alpha7 nicotinic acetylcholine receptor agonists
Biochemical Pharmacology 97: 454

Dani JA, Donnelly-Roberts D, Bertrand D (2013)
Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--editorial comments
Biochemical Pharmacology 86: 1041

Beebe X, Darczak D, Henry RF, Vortherms T, Janis R, Namovic M, Donnelly-Roberts D, Kage KL, Surowy C, Milicic I, Niforatos W, Swensen A, Marsh KC, Wetter JM, Franklin P, Baker S, Zhong C, Simler G, Gomez E, Boyce-Rustay JM, Zhu CZ, Stewart AO, Jarvis MF, Scott VE (2012)
Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca(2)(+) channel blockers with analgesic activity
Bioorganic & Medicinal Chemistry 20: 4128

Namovic MT, Jarvis MF, Donnelly-Roberts D (2012)
High throughput functional assays for P2X receptors
Curr Protoc Pharmacol Chapter 9: Unit 9 15

Donnelly-Roberts D, Bertrand D, Gopalakrishnan M (2011)
Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--Editorial Comments
Biochemical Pharmacology 82: 797

Namovic M, Hu M, Abraham V, Towne D, Lee C-H, Gopalakrishnan M, Esbenshade T, Donnelly-Roberts D (2011)
Poster: A-582941, a pro-cognitive alpha7 nAChR agonist, differentially modulates mitochondrial membrane potential
Biochemical Pharmacology 82: 1027

Perez-Medrano A, Donnelly-Roberts D, Florjancic AS, Nelson DW, Li T, Namovic MT, Peddi S, Faltynek CR, Jarvis MF, Carroll WA (2011)
Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X(7) antagonists
Bioorganic & Medicinal Chemistry Lett 21: 3297

Vortherms TA, Swensen AM, Niforatos W, Limberis JT, Neelands TR, Janis RS, Thimmapaya R, Donnelly-Roberts D, Namovic MT, Zhang D, Brent Putman C, Martin RL, Surowy CS, Jarvis MF, Scott VE (2011)
Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels
Inflamm Res 60: 683

Anderson DJ, Vaidyanathan S, Namovic M, Donnelly-Roberts D, Lee L, Gopalakrishnan M (2009)
Poster: Radioligand binding characterization of [3H]-A-998679: A novel positive allosteric modulator of alpha4/beta2 nAChRs
Biochemical Pharmacology 78: 903

Bertrand D, Gopalakrishnan M, Donnelly-Roberts D (2009)
Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--editorial perspective
Biochemical Pharmacology 78: 657

Carroll WA, Donnelly-Roberts D, Jarvis MF (2009)
Selective P2X(7) receptor antagonists for chronic inflammation and pain
Purinergic Signal 5: 63

Donnelly-Roberts D, Namovic MT, Han P, Jarvis MF (2009)
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
British Journal of Pharmacology 157: 1203

Donnelly-Roberts D, Namovic MT, Surber B, Vaidyanathan SX, Perez-Medrano A, Wang Y, Carroll WA, Jarvis MF (2009)
[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors
Neuropharmacology 56: 223

Donnelly-Roberts D, Malysz J, Faghih R, Gronlien H, Haakerud M, Thorin-Hagne K, Ween H, Gopalakrishnan SM, Hu M, Li J, Anderson DJ, Kohlhaas KL, Namovic M, Radek R, Robb H, Briggs CA, Bitner RS, Bunnelle WH, Gopalakrishnan M (2009)
Poster: Profile of A-716096, a novel thiazolylidine positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor
Biochemical Pharmacology 78: 912

Honore P, Donnelly-Roberts D, Namovic M, Zhong C, Wade C, Chandran P, Zhu C, Carroll W, Perez-Medrano A, Iwakura Y, Jarvis MF (2009)
The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice
Behavioural Brain Research 204: 77

Perez-Medrano A, Donnelly-Roberts D, Honore P, Hsieh GC, Namovic MT, Peddi S, Shuai Q, Wang Y, Faltynek CR, Jarvis MF, Carroll WA (2009)
Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain
Journal of Medicinal Chemistry 52: 3366

Betschmann P, Bettencourt B, Donnelly-Roberts D, Friedman M, George J, Hirst G, Josephsohn N, Konopacki D, Li B, Maull J, Morytko MJ, Moore NS, Namovic M, Rafferty P, Salmeron-Garcia JA, Tarcsa E, Wang L, Woller K (2008)
Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists
Bioorganic & Medicinal Chemistry Lett 18: 3848

Donnelly-Roberts D, McGaraughty S, Shieh CC, Honore P, Jarvis MF (2008)
Painful purinergic receptors
Journal of Pharmacology & Experimental Therapeutics 324: 409

Florjancic AS, Peddi S, Perez-Medrano A, Li B, Namovic MT, Grayson G, Donnelly-Roberts D, Jarvis MF, Carroll WA (2008)
Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists
Bioorganic & Medicinal Chemistry Lett 18: 2089

Morytko MJ, Betschmann P, Woller K, Ericsson A, Chen H, Donnelly-Roberts D, Namovic MT, Jarvis MF, Carroll WA, Rafferty P (2008)
Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists
Bioorganic & Medicinal Chemistry Lett 18: 2093

Nelson DW, Sarris K, Kalvin DM, Namovic MT, Grayson G, Donnelly-Roberts D, Harris R, Honore P, Jarvis MF, Faltynek CR, Carroll WA (2008)
Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists
Journal of Medicinal Chemistry 51: 3030

Carroll WA, Kalvin DM, Perez Medrano A, Florjancic AS, Wang Y, Donnelly-Roberts D, Namovic MT, Grayson G, Honore P, Jarvis MF (2007)
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists
Bioorganic & Medicinal Chemistry Lett 17: 4044

Donnelly-Roberts D, Jarvis MF (2007)
Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states
British Journal of Pharmacology 151: 571

McGaraughty S, Chu KL, Namovic MT, Donnelly-Roberts D, Harris RR, Zhang XF, Shieh CC, Wismer CT, Zhu CZ, Gauvin DM, Fabiyi AC, Honore P, Gregg RJ, Kort ME, Nelson DW, Carroll WA, Marsh K, Faltynek CR, Jarvis MF (2007)
P2X7-related modulation of pathological nociception in rats
Neuroscience 146: 1817

Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF (2006)
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Journal of Pharmacology & Experimental Therapeutics 319: 1376

Kolasa T, Matulenko MA, Hakeem AA, Patel MV, Mortell K, Bhatia P, Henry R, Nakane M, Hsieh GC, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts D, Namovic MT, Hollingsworth PR, Martino B, El Kouhen O, Marsh KC, Wetter JM, Moreland RB, Brioni JD, Stewart AO (2006)
1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction
Journal of Medicinal Chemistry 49: 5093

Nelson DW, Gregg RJ, Kort ME, Perez-Medrano A, Voight EA, Wang Y, Grayson G, Namovic MT, Donnelly-Roberts D, Niforatos W, Honore P, Jarvis MF, Faltynek CR, Carroll WA (2006)
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists
Journal of Medicinal Chemistry 49: 3659

Patel MV, Kolasa T, Mortell K, Matulenko MA, Hakeem AA, Rohde JJ, Nelson SL, Cowart MD, Nakane M, Miller LN, Uchic ME, Terranova MA, El-Kouhen OF, Donnelly-Roberts D, Namovic MT, Hollingsworth PR, Chang R, Martino BR, Wetter JM, Marsh KC, Martin R, Darbyshire JF, Gintant G, Hsieh GC, Moreland RB, Sullivan JP, Brioni JD, Stewart AO (2006)
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzam ide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction
Journal of Medicinal Chemistry 49: 7450

Rueter LE, Donnelly-Roberts D, Curzon P, Briggs CA, Anderson DJ, Bitner RS (2006)
A-85380: a pharmacological probe for the preclinical and clinical investigation of the alphabeta neuronal nicotinic acetylcholine receptor
CNS Drug Rev 12: 100

Chen YW, Donnelly-Roberts D, Namovic MT, Gintant GA, Cox BF, Jarvis MF, Harris RR (2005)
Pharmacological characterization of P2X7 receptors in rat peritoneal cells
Inflamm Res 54: 119

Nakane M, Cowart MD, Hsieh GC, Miller L, Uchic ME, Chang R, Terranova MA, Donnelly-Roberts D, Namovic MT, Miller TR, Wetter JM, Marsh K, Stewart AO, Brioni JD, Moreland RB (2005)
2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist
Neuropharmacology 49: 112

Adams MR, Nikkel AL, Donnelly-Roberts D, Watt AT, Johnston JF, Cowsert LM, Butler M, Kroeger PE, Frost L, Curzon P, Decker MW, Bitner RS (2004)
In vitro and in vivo effects of an alpha3 neuronal nicotinic acetylcholine receptor antisense oligonucleotide
Brain Research Mol Brain Res 129: 67

Brioni JD, Moreland RB, Cowart M, Hsieh GC, Stewart AO, Hedlund P, Donnelly-Roberts D, Nakane M, Lynch JJ, 3rd, Kolasa T, Polakowski JS, Osinski MA, Marsh K, Andersson KE, Sullivan JP (2004)
Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats
Proc Natl Acad Sci U S A 101: 6758

Cowart M, Latshaw SP, Bhatia P, Daanen JF, Rohde J, Nelson SL, Patel M, Kolasa T, Nakane M, Uchic ME, Miller LN, Terranova MA, Chang R, Donnelly-Roberts D, Namovic MT, Hollingsworth PR, Martino BR, Lynch JJ, 3rd, Sullivan JP, Hsieh GC, Moreland RB, Brioni JD, Stewart AO (2004)
Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction
Journal of Medicinal Chemistry 47: 3853

Donnelly-Roberts D, Namovic MT, Faltynek CR, Jarvis MF (2004)
Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells
Journal of Pharmacology & Experimental Therapeutics 308: 1053

Hsieh GC, Hollingsworth PR, Martino B, Chang R, Terranova MA, O'Neill AB, Lynch JJ, Moreland RB, Donnelly-Roberts D, Kolasa T, Mikusa JP, McVey JM, Marsh KC, Sullivan JP, Brioni JD (2004)
Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine
Journal of Pharmacology & Experimental Therapeutics 308: 330

Matulenko MA, Hakeem AA, Kolasa T, Nakane M, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts D, Namovic MT, Moreland RB, Brioni JD, Stewart AO (2004)
Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonists
Bioorganic & Medicinal Chemistry 12: 3471

Matulenko MA, Surber B, Fan L, Kolasa T, Nakane M, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts D, Namovic MT, Moreland RB, Brioni JD, Stewart AO (2004)
Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand
Bioorganic & Medicinal Chemistry Lett 14: 5095

Moreland RB, Nakane M, Donnelly-Roberts D, Miller LN, Chang R, Uchic ME, Terranova MA, Gubbins EJ, Helfrich RJ, Namovic MT, El-Kouhen OF, Masters JN, Brioni JD (2004)
Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5)
Biochemical Pharmacology 68: 761

Rueter LE, Anderson DJ, Briggs CA, Donnelly-Roberts D, Gintant GA, Gopalakrishnan M, Lin NH, Osinski MA, Reinhart GA, Buckley MJ, Martin RL, McDermott JS, Preusser LC, Seifert TR, Su Z, Cox BF, Decker MW, Sullivan JP (2004)
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders
CNS Drug Rev 10: 167

Stewart AO, Cowart MD, Moreland RB, Latshaw SP, Matulenko MA, Bhatia PA, Wang X, Daanen JF, Nelson SL, Terranova MA, Namovic MT, Donnelly-Roberts D, Miller LN, Nakane M, Sullivan JP, Brioni JD (2004)
Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning
Journal of Medicinal Chemistry 47: 2348

Gopalakrishnan SM, Moreland RB, Kofron JL, Helfrich RJ, Gubbins E, McGowen J, Masters JN, Donnelly-Roberts D, Brioni JD, Burns DJ, Warrior U (2003)
A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptors
Analytical Biochemistry 321: 192

Bitner RS, Nikkel AL, Curzon P, Donnelly-Roberts D, Puttfarcken PS, Namovic M, Jacobs IC, Meyer MD, Decker MW (2000)
Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat
Brain Research 871: 66

Bannon AW, Decker MW, Holladay MW, Curzon P, Donnelly-Roberts D, Puttfarcken PS, Bitner RS, Diaz A, Dickenson AH, Porsolt RD, Williams M, Arneric SP (1998)
Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors
Science 279: 77

Decker MW, Curzon P, Holladay MW, Nikkel AL, Bitner RS, Bannon AW, Donnelly-Roberts D, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Williams M, Arneric SP (1998)
The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594
Journal de Physiologie (Paris) 92: 221

Donnelly-Roberts D, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP (1998)
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization
Journal of Pharmacology & Experimental Therapeutics 285: 777

Holladay MW, Bai H, Li Y, Lin NH, Daanen JF, Ryther KB, Wasicak JT, Kincaid JF, He Y, Hettinger AM, Huang P, Anderson DJ, Bannon AW, Buckley MJ, Campbell JE, Donnelly-Roberts D, Gunther KL, Kim DJ, Kuntzweiler TA, Sullivan JP, Decker MW, Arneric SP (1998)
Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice
Bioorganic & Medicinal Chemistry Lett 8: 2797

Holladay MW, Wasicak JT, Lin NH, He Y, Ryther KB, Bannon AW, Buckley MJ, Kim DJ, Decker MW, Anderson DJ, Campbell JE, Kuntzweiler TA, Donnelly-Roberts D, Piattoni-Kaplan M, Briggs CA, Williams M, Arneric SP (1998)
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors
Journal of Medicinal Chemistry 41: 407

Lin NH, Gunn DE, Li Y, He Y, Bai H, Ryther KB, Kuntzweiler T, Donnelly-Roberts D, Anderson DJ, Campbell JE, Sullivan JP, Arneric SP, Holladay MW (1998)
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist
Bioorganic & Medicinal Chemistry Lett 8: 249

Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campbell JE, Decker MW, Donnelly-Roberts D, Elliott RL, Gopalakrishnan M, Holladay MW, Hui YH, Jackson WJ, Kim DJ, Marsh KC, O'Neill A, Prendergast MA, Ryther KB, Sullivan JP, Arneric SP (1997)
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo
Pharmacol Biochem Behav 57: 231

Lin NH, Gunn DE, Ryther KB, Garvey DS, Donnelly-Roberts D, Decker MW, Brioni JD, Buckley MJ, Rodrigues AD, Marsh KG, Anderson DJ, Buccafusco JJ, Prendergast MA, Sullivan JP, Williams M, Arneric SP, Holladay MW (1997)
Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties
Journal of Medicinal Chemistry 40: 385

Puttfarcken PS, Manelli AM, Arneric SP, Donnelly-Roberts D (1997)
Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells
Journal of Neurochemistry 69: 930

Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Xue IC, Piattoni-Kaplan M, Molinari E, Campbell JE, McKenna DG, Gunn DE, Lin NH, Ryther KB, He Y, Holladay MW, Wonnacott S, Williams M, Arneric SP (1997)
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties
Journal of Pharmacology & Experimental Therapeutics 283: 235

Abreo MA, Lin NH, Garvey DS, Gunn DE, Hettinger AM, Wasicak JT, Pavlik PA, Martin YC, Donnelly-Roberts D, Anderson DJ, Sullivan JP, Williams M, Arneric SP, Holladay MW (1996)
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
Journal of Medicinal Chemistry 39: 817

Donnelly-Roberts D, Xue IC, Arneric SP, Sullivan JP (1996)
In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
Brain Research 719: 36

Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, Sullivan JP (1996)
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor
Journal of Pharmacology & Experimental Therapeutics 276: 289

Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M, Arneric SP (1996)
A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand
Neuropharmacology 35: 725

Arneric SP, Sullivan JP, Decker MW, Brioni JD, Bannon AW, Briggs CA, Donnelly-Roberts D, Radek RJ, Marsh KC, Kyncl J, Williams M, Buccafusco JJ (1995)
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties
Alzheimer Disease & Associated Disorders 9 Suppl 2: 50

Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts D, Kang CH, O'Neill AB, Piattoni-Kaplan M, Swanson S, Sullivan JP (1995)
Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors
European Journal of Pharmacology 280: 79

Donnelly-Roberts D, Arneric SP, Sullivan JP (1995)
Functional modulation of human ganglionic-like neuronal nicotinic acetylcholine receptors (nAChRs) by L-type calcium channel antagonists
Biochemical & Biophysical Research Communications 213: 657

Gopalakrishnan M, Buisson B, Touma E, Giordano T, Campbell JE, Hu IC, Donnelly-Roberts D, Arneric SP, Bertrand D, Sullivan JP (1995)
Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor
European Journal of Pharmacology 290: 237

Sullivan JP, Decker MW, Donnelly-Roberts D, Brioni JD, Bannon AW, Holladay MW, Anderson DJ, Briggs CA, Williams M, Arneric SP (1995)
Cholinergic channel activators: novel opportunities for the treatment of CNS disorders
Proc West Pharmacol Soc 38: 127

Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS (1994)
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization
Journal of Pharmacology & Experimental Therapeutics 270: 310

Mihovilovic M, Donnelly-Roberts D, Richman DP, Martinez-Carrion M (1994)
Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity
J Immunol 152: 5997

Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Bannon AW, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ (1994)
(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors
Journal of Pharmacology & Experimental Therapeutics 271: 624

Chaturvedi V, Donnelly-Roberts D, Lentz TL (1993)
Effects of mutations of Torpedo acetylcholine receptor alpha 1 subunit residues 184-200 on alpha-bungarotoxin binding in a recombinant fusion protein
Biochemistry 32: 9570

Donnelly-Roberts D, Lentz TL (1993)
Sodium dodecyl sulfate- and carbamylcholine-induced changes in circular dichroism spectra of acetylcholine receptor synthetic peptides
Brain Research Mol Brain Res 19: 55

Chaturvedi V, Donnelly-Roberts D, Lentz TL (1992)
Substitution of Torpedo acetylcholine receptor alpha 1-subunit residues with snake alpha 1- and rat nerve alpha 3-subunit residues in recombinant fusion proteins: effect on alpha-bungarotoxin binding
Biochemistry 31: 1370

Donnelly-Roberts D, Lentz TL (1991)
Binding sites for alpha-bungarotoxin and the noncompetitive inhibitor phencyclidine on a synthetic peptide comprising residues 172-227 of the alpha-subunit of the nicotinic acetylcholine receptor
Biochemistry 30: 7484

Donnelly-Roberts D, Lentz TL (1991)
Structural and conformational similarity between synthetic peptides of curaremimetic neurotoxins and rabies virus glycoprotein
Brain Research Mol Brain Res 11: 107

Donnelly-Roberts D, Lentz TL (1989)
Antibodies against an alpha-bungarotoxin-binding peptide of the alpha-subunit of the acetylcholine receptor
Biochemical & Biophysical Research Communications 160: 289

Donnelly-Roberts D, Lentz TL (1989)
Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor
Pept Res 2: 221

Lentz TL, Hawrot E, Donnelly-Roberts D, Wilson PT (1988)
Synthetic peptides in the study of the interaction of rabies virus and the acetylcholine receptor
Adv Biochem Psychopharmacol 44: 57